North Carolina macular dystrophy (NCMD) is an autosomal dominant macular disease, was mapped to 6q14-q16.2, the disease-causing gene has yet not been identified. It shares phenotypic similarity with age-related macular degeneration including drusen and choroidal neovascularization. We collected six families with NCMD including 75 members, and conducted clinical characterization and genetic mapping for these families. Forty-five patients were diagnosed as NCMD; all six NCMD families were mapped to MCDR1 locus using genetic linkage analysis. MCDR1 interval was refined to 3 cM (1.8mb) between D6S1716 to D6S1671 via fine mapping using microsatellite markers in these six families, all eleven annotated genes within the interval were analyzed by mutation screening in coding regions, no mutation was found, suggesting a potential novel gene or a new pathological mechanism causing NCMD. The refinement of MCDR1 locus will aid the disease-causing gene identification. Functional studies of NCMD genes should provide important insights into pathogenetic mechanisms of NCMD and age-related macular degeneration.
Introduction
The inherited macular dystrophies are characterized by bilateral visual loss and the finding of generally symmetrical macular abnormalities, they can present as genetic heterogeneity including autosomal dominant, autosomal recessive, X linked recessive and mitochondrial inheritance. NCMD is an autosomal dominant, highly penetrant disease with congenital or infantile onset. NCMD shares many important clinical and histopathological similarities with AMD including an abnormal accumulation of drusen, atrophy of the RPE and overlying photoreceptor cells, choroidal neovascularizatioon and loss of central vision (Small, Hermsen, Gurney, Fetkenhour, & Folk, 1992) . Lefler, Wadsworth, and Sidbury (1971) reported a large family with multiple generations from North Carolina that was affected with a form of drusen and macular degeneration, therefore the term North Carolina macular dystrophy. North Carolina macular dystrophy has been described under different names such as central areolar pigment epithelial dystrophy (CAPED), central pigment epithelial and choroidal degeneration, and central retinal pigment epithelial dystrophy in several branches of a large family (Frank, Landers, Williams, & Sidbury, 1974; Small, Hermsen et al., 1992) . The disease in this family was apparently inherited 0042-6989/$ -see front matter Ó 2007 Elsevier Ltd. All rights reserved. doi:10.1016/j.visres.2007.09. 015 from three founding Irish brothers who lived in the late eighteenth and early nineteenth centuries (Frank et al., 1974; Small, Hermsen et al., 1992) . It is generally non-progressive and shows a wide range of intrafamilial and interfamilial variations in clinical phenotypes. These clinical manifestations can be divided into three grades. Grade I represents drusen in the central macula. Grade II denotes subretinal neovascularization or scar. Grade III exhibits well-demarcated chorioretinal atrophy with hyperpigmentation on the edge of the lesion. A large family with North Carolina macular dystrophy inherited as an autosomal dominant, fully penetrant trait was studied. Linkage analysis of this kindred, now known to include more than 2000 individuals, localized the disease-causing gene to chromosome 6q16 between D6S275 and D6S475 in a 4.5 cM interval. This locus has been designated by Online Mendelian Inheritance of Man (OMIM) as MCDR1, for macular degeneration locus 1 (OMIM #136550) (Small et al., 1999; Small, Weber, Roses, & Pericak-Vance, 1993; Small, Weber et al., 1992) . Several European and South American families with a NCMD phenotype were also localized to the MCDR1 locus, supporting its role as a significant cause of childhood macular degeneration (Rabb, Mullen, Yelchits, Udar, & Small, 1998; Reichel et al., 1998; Sauer et al., 1997; Small, Garcia, Gallardo, Udar, & Yelchits, 1998; Small, Puech, Mullen, & Yelchits, 1997) . We performed clinic study and linkage mapping in six families with NCMD and refined MCDR1 to 1.8 million base pairs.
Methods

Study subjects
This project was approved by the Institutional Board of the Institute of Ophthalmology and the Institutional Review Board of the University of Utah Health Science Center, USA. Informed consent was obtained from all participants. Seventy five members from six families were included; all participatants underwent ophthalmic examination including best corrected Snellen visual acuity determination and fundus examination. Fluorescein angiography was carried out on some patients. Affected patients were designated on the basis of decrease visual acuity and the macular lesions.
Establishment of cell lines and DNA and RNA isolation
Blood was collected by venepuncture, Lymphoblastoid cell lines were established by Epstein-Bar virus transformation of peripheral mononuclear cells as previously described (Chou et al., 1992) . Haploid somatic hybrids cell lines were established using a GMP Conversion Technology (Yan, Papadopoulos et al., 2000) . Genomic DNA and RNA was isolated from the blood samples, EBV-transformed lymphoblastoid cells and haploid somatic hybrids using a Puregene genomic DNA purification kit or VERSAGENE TM RNA Kit (Gentra Systems, Minneapolis, Massachusetts, USA). cDNA was made using SuperScript TM III First-Strand Synthsis Sytem for RT-PCR (Invitrogen Corporation, Carlsbad, CA).
Genotyping and linkage analysis
In order to obtain a high density coverage of STR markers in the Minimum Genetic Interval (MGI), we first determined the precise physical location of each known STR marker listed on the Marshfield genetic maps (http://research.marshfieldclinic.org/genetics/GeneticResearch/compMaps.asp) by using public NCBI (http://www.ncbi.nlm.nih.gov/) and UCSC (http://genome.ucsc.edu/) databases (Table 1) . To generate additional STR markers, we searched genomic DNA sequences from public NCBI and UCSC databases and identified 30 potential candidates. These potential STR markers included CA, ATA, GATA, GAAG repeats. We then tested the degree of polymorphisms of these STR markers by genotyping them on six North Carolina macular dystrophy families and 100 unrelated Caucasian individuals.
Twenty-six of these 30 STR markers appeared to be informative and highly polymorphic and were used in genotyping analyses (Table 1) . This approach allowed us to saturate the MGI with STR markers with an average coverage of 100 kb between two STR markers and determine the linear order of markers (Table 1) .
Thirty STR markers were genotyped using the primers either found from Marshfield Clinic or designed by ourselves. The genotyping was performed using P 32 labeling method using genomic DNA isolated from blood (Yang et al., 2002; Zhang et al., 2001) . Two-point LOD scores were calculated using the subroutine MLINK of the LINKAGE program (v.5.1; http://www.hgmp.mrc.ac.uk/; Human Genome Mapping Project Resources Center, Cambridge, UK) (Lathrop, Lalouel, Julier, & Ott, 1984; Lathrop, Lalouel, Julier, & Ott, 1985) . An autosomal-dominant mode of inheritance with full penetrance and a disease allele frequency of 0.0001 were assumed in the computations.
Results
Clinical evaluation
Six multiple generation pedigrees (324, 348, 71, 633, 419 , and 3784) with NCMD were identified for study ( Fig. 1 ). Family 324, 348, 71, 633 and 3784 are of Caucasian origin whereas family 419 is of Chinese origin. These pedigrees revealed autosomal dominant inheritance, with affected members in each generation. Clinical evaluation and genetic studies on Family 324 were previously published (Reichel et al., 1998) . Family 3784 was referred by an ophthalmologist with documented fundus photographs on affected patients. Thus careful clinical evaluations were performed in every individual to ensure an accurate diagnosis. A complete ophthalmic history and examination was performed on each patient. This included assessment of visual acuity, and detailed examination of the anterior segment and fundus. Individuals were diagnosed to be affected if they had decreased visual acuity along with macular atrophy, or if drusen were found in the posterior pole. Color fundus photographs were obtained for all affected individuals. At least four affected individuals in each kindred underwent fluorescein angiography. Forty two affected patients in NCMD families demonstrated a wide range of clinical phenotypes, including confluent drusen in the macula Fig. 2a , b, and d), choroidal neovascularization (Fig. 2f, g, and h ), subretinal scars (Fig. 2e) , or macular staphloma (Fig. 2c) .
Generation of EBV-transformed lymphoblastoid cell lines and haploid somatic hybrids
EBV transformed lymphoblastoid cell lines from three affected and two normal individuals in each kindred were established. In addition, using a GMP Conversion Technology (Yan, Papadopoulos et al., 2000) we were able to separate normal and MCDR1 containing chromosomes and create haploid somatic hybrid cell lines (haploid samples) for one affected patient in family 348, 324, 71, 633, 419 and 3784. Since there is no normal allele to mask a disease allele, haploid samples allow one to unambiguously determine a disease haplotype, or identify a mutation (Yan, Kinzler, & Vogelstein, 2000) .
Genetic linkage analysis
Because the clinical features observed in family 348, 324, 71, 633, 419 , and 3784 were characteristic of NCMD, genetic linkage mapping for the responsible gene was conducted using DNA markers linked to the locus for MCDR1 on chromosomal 6q16 using established methods (Garibaldi & Zhang, 1999; Kniazeva et al., 1999; Kniazeva et al., 2000) . Positive linkage to the MCDR1 locus was observed ( Table 2 ). The likelihood (two point lod scores) of linkage between locus D6S1284, D6S1717, and D6S475 and the MCDR1 locus was determined (Table 2 ). The maximum lod score, 15.8, was achieved with marker D6S1717 at recombination fraction 0. To further refine the minimal genetic interval, haplotypes of individuals in each family were analyzed for recombination events. We genotyped additional 23 STR markers and identified haplotypes which segregated with disease (Table 1) . Individuals with recombinant haplotypes are indicated (as an X) in Table 1 . One recombination event occurred at D6S249, D6S1284, and D6S1716 in individual #0348004 of family 348 ( Fig. 1  & Table 1 ), another occurred at D6S475 in individual #0633001 of family 663 ( Fig. 1 and Table 1 ). Therefore, haplotype analyses suggest that the disease gene is most likely located in the interval between locus D6S1716 and D6S1671, corresponding to 1.86 million bps and containing 10 known or predicted genes (Table 1) .
Completion of a high-resolution genetic linkage map of the MCDR1 locus
As the first step in positional cloning of MCDR1, we performed fine linkage mapping in order to establish a ferent independent families are investigated. This analysis is particularly useful to refine a MGI due to an ancestral founder mutation. We compared the disease allele of each STR marker of six North Carolina macular dystrophy families to construct extended disease haplotypes (Fig. 1) . This analysis revealed that the family 348, 324, and 71 shared an identical disease haplotype between D6S1284 and S6-170561, indicating that they originated from an ancestral founder mutation. However, haplotypes of these three families diverged at marker D6S1671. Therefore the MGI has been refined to a region between marker D6S1716 (98.85 mb) and D6S1671 (100.66 mb), corresponding to approximately 1.81 mb (Table 1) .
The examination of candidate genes for MCDR1
A search for potential genes using public human genome databases revealed 10 known or predicted genes within the 1.8 million base pairs of interval (POU3F2, FBXL4, LOC389416, C6orf168, COQ3, C6orf111, USP45, LOC401270, CCNC, PRDM13 and MCHR2). All exons and cDNA of the 11 genes were analyzed. Unfortunately, we have not identified any DNA alteration in the coding region or splicing junctions that provide convincing evidence that they cause North Carolina macular dystrophy phenotype. 
Discussion
Over the past decade, much progress has been made in identifying genes for juvenile macular dystrophy. Many loci for macular dystrophy have been mapped and six genes cloned (Allikmets et al., 1997; Heon et al., 1996; Kniazeva et al., 2000; Michaelides, Hunt, & Moore, 2003; Nichols et al., 1993; Petrukhin et al., 1998; Sun, Molday, & Nathans, 1999; Weber, Vogt, Wolz, Ives, & Ewing, 1994; Wells et al., 1993; Weng et al., 1999; Zhang et al., 2001 ). Functional studies of these genes have provided important insights into pathogenetic mechanisms of macular degeneration. For example, ABCR is the protein product of the recessive Stargardt macular dystrophy gene, ABCA4, that functions as an outwardly directed flippase for removal of N-retinyliden-phosphatidylethanolamine (A2E, (Gregory et al., 1996; Stone et al., 1999) ). ELOVL4 is mutated in dominant Stargardt macular dystrophy and encodes an enzyme involved in elongation of very long chain fatty acid (Cameron et al., 2007; Karan et al., 2005; Zhang et al., 2001) .
It is important to study the genetic basis of North Carolina macular dystrophy, as it causes juvenile macular degeneration with visual impairment. Furthermore, the significance of proposed studies on North Carolina macular dystrophy lies in its relationship with AMD. North Carolina macular dystrophy shares important clinical features with age-related macular degeneration (AMD). Drusen is a hallmark of AMD and choroidal neovascularization (CNV) is one of the most important complications of AMD. Both of them are present in patients with North Carolina macular dystrophy. Therefore, these observations make North Carolina macular dystrophy a unique genetic model for AMD. NCDR1 was initially mapped to 6q16 and then refined to an interval between D6S249 and D6S1671 (Small, Weber et al., 1992; Small et al. 1999) . Through this study, we refined MCDR1 interval to 1.81 mb between D6S1716 and D6S1671. No disease-causing mutation was identified in the candidate genes within the interval suggesting that MCDR1 mutations may lie in a novel gene or caused a new pathogenic mechanism. Understanding the molecular mechanisms of MCDR1 should lead to novel insights into the pathogenesis of macular degeneration. Elucidation of the function of the MCDR1 gene may increase our understanding of retinal cell biology in general and drusen formation in particular. 
